ACE variants and association with brain Aβ levels in Alzheimer's disease

被引:0
|
作者
Miners, J. Scott [1 ]
van Helmond, Zoe [1 ]
Raiker, Merryn [1 ]
Love, Seth [2 ]
Kehoe, Patrick G. [1 ]
机构
[1] Univ Bristol, Inst Clin Neurosci, Dementia Res Grp, Bristol BS16 1LE, Avon, England
[2] Univ Bristol, Inst Clin Neurosci, Dept Neuropathol, Bristol BS16 1LE, Avon, England
来源
关键词
Alzheimer's disease; angiotensin; ACE; amyloid; neuropathology; soluble A beta; insoluble A beta; SNP; association; A beta degrading enzyme; cerebral blood flow; hypertension;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ACE is a candidate gene for Alzheimer's disease (AD) and associations have been reported between ACE variants and plasma ACE levels, AD risk, AD age at onset of disease and cerebrospinal fluid levels of A beta. Despite evidence that ACE can degrade A beta, the relationships between ACE variants and the levels of different types of A beta in the brain are not known. We have investigated the relationship between AD-associated ACE variants, for which the associations with brain activity of ACE were previously analysed, and brain homogenate levels of soluble, insoluble and oligomeric A beta. Reported AD risk variants in the ACE indel (rs1799752) and its 'proxy' rs4343 were significantly associated with soluble A beta level in AD only (p=0.001), as was rs1800764 but less so (p=0.014). In contrast, insoluble A beta was associated with ACE indel and rs4343 variants in controls only (p < 0.01). No associations were found for oligomeric A beta. These data indicate a complex relationship between ACE and A beta that differs between AD and control brains.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 50 条
  • [31] Brain Bromine Levels Associated with Alzheimer's Disease Neuropathology
    Agarwal, Puja
    Brockman, John D.
    Wang, Yamin
    Schneider, Julie A.
    Morris, Martha C.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (01) : 327 - 332
  • [32] Regional levels of brain phospholipase Cγ in Alzheimer's disease
    Zhang, DQ
    Dhillon, H
    Prasad, MR
    Markesbery, WR
    BRAIN RESEARCH, 1998, 811 (1-2) : 161 - 165
  • [33] Altered levels of cholinesterase splice variants in Parkinson's and Alzheimer's disease brains
    Gok, M.
    Madrer, N.
    Bodur, E.
    Greenberg, D.
    Soreq, H.
    FEBS OPEN BIO, 2021, 11 : 24 - 24
  • [34] The association between ACE I/D polymorphism and the risk of Alzheimer's disease in Lebanon
    El Shamieh, Said
    Saleh, Fatima
    Masri, Niveen
    Fakhoury, Hana M.
    Fakhoury, Rajaa
    META GENE, 2018, 18 : 191 - 194
  • [35] Blood type gene locus has no influence on ACE association with Alzheimer's disease
    Braae, Anne
    Medway, Christopher
    Carrasquillo, Minerva
    Younkin, Steven
    Kehoe, Patrick G.
    Morgan, Kevin
    NEUROBIOLOGY OF AGING, 2015, 36 (04) : 1767.e1 - 1767.e2
  • [36] The ACE gene and Alzheimer's disease susceptibility
    Narain, Y
    Yip, A
    Murphy, T
    Brayne, C
    Easton, D
    Evans, JG
    Xuereb, J
    Cairns, N
    Esiri, MM
    Furlong, RA
    Rubinsztein, DC
    JOURNAL OF MEDICAL GENETICS, 2000, 37 (09) : 695 - 697
  • [37] The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology
    Cui, Huan
    Su, Si
    Cao, Yan
    Ma, Chao
    Qiu, Wenying
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [38] Association of genetic variants of ABCA1 with Alzheimer's disease risk
    Rodriguez-Rodriguez, Eloy
    Mateo, Ignacio
    Llorca, Javier
    Sanchez-Quintana, Coro
    Infante, Jon
    Garcia-Gorostiaga, Ines
    Sanchez-Juan, Pascual
    Berciano, Jose
    Combarros, Onofre
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2007, 144B (07) : 964 - 968
  • [39] No association of CDK5 genetic variants with Alzheimer's disease risk
    Vazquez-Higuera, Jose Luis
    Mateo, Ignacio
    Sanchez-Juan, Pascual
    Rodriguez-Rodriguez, Eloy
    Infante, Jon
    Berciano, Jose
    Combarros, Onofre
    BMC MEDICAL GENETICS, 2009, 10
  • [40] Association of ABC-transporter variants with an increased risk of Alzheimer's disease
    Flueh, C.
    Remmler, C.
    Haenisch, S.
    Faltraco, F.
    Warzok, R. W.
    Vogelgesang, S.
    Cascorbi, I.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 381 : 87 - 88